Twin SUBLIVAC® Grasses Clinical Efficacy Study

NCT ID: NCT00422149

Last Updated: 2012-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To show that treatment with SUBLIVAC® Grasses is clinically effective by means of reduction in allergic symptoms and/or use of allergic symptomatic medication in subjects suffering from IgE mediated allergic complaints triggered by grass pollen.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Indication under study: IgE mediated allergic disorders triggered by grass pollen.

Number of centres: approximately 50.

Study period planned: Q2-2006 until Q3-2008 Analysis after one exposed season (2007); based on the outcome the study will be stopped or continued for another season.

Subject selection criteria: Seasonal rhinitis and/or rhinoconjunctivitis with or without mild asthma (FEV1 \> 70%) related to grass pollen, age 12 years or older.

Dosage schedule: Start with two drops daily of SUBLIVAC® and increase by two drops daily, until the maintenance dose of 10 drops SUBLIVAC® GrassesSUBLIVAC® Grasses is reached.

Route of administration: Sublingual application (drops are to be held underneath the tongue for 2-3 minutes and then will be swallowed).

Duration of treatment: 6 to 12 months blinded per subject . Efficacy parameters

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhinitis, Allergic, Seasonal Conjunctivitis, Allergic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

SUBLIVAC® Grasses treatment

Group Type ACTIVE_COMPARATOR

SUBLIVAC® Grasses/Placebo treatment

Intervention Type DRUG

SUBLIVAC® Grasses/Placebo treatment

SUBLIVAC® Grasses treatment

Intervention Type DRUG

SUBLIVAC® Grasses treatment

2

Placebo treatment

Group Type PLACEBO_COMPARATOR

SUBLIVAC® Grasses/Placebo treatment

Intervention Type DRUG

SUBLIVAC® Grasses/Placebo treatment

Placebo treatment

Intervention Type DRUG

Placebo treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SUBLIVAC® Grasses/Placebo treatment

SUBLIVAC® Grasses/Placebo treatment

Intervention Type DRUG

SUBLIVAC® Grasses treatment

SUBLIVAC® Grasses treatment

Intervention Type DRUG

Placebo treatment

Placebo treatment

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with allergic rhinoconjunctivitis with or without mild asthma FEV1 ≥ 70%) for at least 2 years. Their allergic symptoms should be related to grass pollen Use of anti-allergy symptomatic medication in the last pollen season (or, in case of a low pollen season, in one of the two previous years)
* A positive skin prick test (\>3 mm) for early flowering treesgrasses and specific serum IgE-test(\>1 U/ml) for grass pollen (Lolium perenne, Phleum pratense and Poa pratensis).

Exclusion Criteria

* A positive SPT for perennial allergens of house dust mite
* Allergy to any of the excipients
* Symptoms related to concomitant sensitisation to perennial allergens of pets
* Chronic asthma or emphysema, particularly with a FEV1 \< 70 % of predicted value or use of inhalation corticosteroids outside grass and tree pollen season for more than two episodes and/or longer than fourteen days
* Use of symptomatic medication for more than three episodes and/or longer than three days outside the tree- or grass pollen season
* Serious immuno-pathological diseases or malignancies (including auto-immune diseases, tuberculosis, HIV)
* Inflammation and infection of the target organ
* Severe atopic dermatitis requiring systemic immuno-suppressive medication
* Allergen specific immuno-therapy treatment within the last 5 years for a period longer than three months
* History of life threatening anaphylactic events, including anaphylactic food allergy, insect venom anaphylaxis, exercise or drug induced anaphylaxis
* A positive pregnancy test, lactation or inadequate contraceptive measures Alcohol- or drug abuse
* Lack of co-operation or severe psychological disorders
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HAL Allergy

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

HAL Allergy BV

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

R Peter, Prof.Dr.med

Role: PRINCIPAL_INVESTIGATOR

Zentrum für Klinische Forschung, Helholzstrasse 8/1, 89081 Ulm, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. P. van Durme

Antwerp, , Belgium

Site Status

Centrum Gespecialiseerde Geneeskunde Genk

Genk, , Belgium

Site Status

UZ Gent, Dienst NKO, 1P1

Ghent, , Belgium

Site Status

UZ Gasthuisberg, Afd. Allergie/Immunologie

Leuven, , Belgium

Site Status

UZ Gasthuisberg, Dienst Kindergeneeskunde

Leuven, , Belgium

Site Status

UZ Gasthuisberg, lokatie St. Rafaël

Leuven, , Belgium

Site Status

Kinderallergie-Astma kinderz.

Mechelen, , Belgium

Site Status

Allergologie Aachen

Aachen, , Germany

Site Status

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Studienzentrum Berlin

Berlin, , Germany

Site Status

Allergologie Braunschweig

Braunschweig, , Germany

Site Status

Priv.-Doz. Hals-Nasen-Ohrenheilkunde plastische Operationen Allergologie

Darmstadt, , Germany

Site Status

Allergologie Dorsten

Dorsten, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Dortmund

Dortmund, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Duisburg

Duisburg, , Germany

Site Status

Medi-Center Düren

Düren, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Düsseldorf

Düsseldorf, , Germany

Site Status

Heinrich-Heine-Universität Düsseldorf, Hautklinik

Düsseldorf, , Germany

Site Status

Universität Erlangen, Poliklinik für Kinder und Jugendliche

Erlangen, , Germany

Site Status

Gemeinschaftspraxis Dr. M. Feldmann und Dr. N. Karadiakos

Essen, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Essen

Essen, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Essen

Essen, , Germany

Site Status

Allergologie Gifhorn

Gifhorn-Winkel, , Germany

Site Status

Drobnitzky Franz-Josef Dr.med. Kinderarzt-Allergologie und Frank-Peter Dr.med. Kinderarzt-Neonatologie Gemeinschaftspraxis

Gütersloh, , Germany

Site Status

Klinik für Pneumologie, Intensiv- und Schlafmedizin Klinikum

Hanover, , Germany

Site Status

Med.Hochschule Hannover, Kinderklinik

Hanover, , Germany

Site Status

Allergologie Jülich

Jülich, , Germany

Site Status

Allergologie Kassel

Kassel, , Germany

Site Status

HNO - Krefeld

Krefeld, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Lüdenscheid

Lüdenscheid, , Germany

Site Status

Allgemeinmedizin Stockach, Baden

Stockach, , Germany

Site Status

Zentrum für Klinische Forschung, Helmholtzstrasse 8/1, 89081 Ulm, Germany

Ulm, , Germany

Site Status

Gemeinschaftspraxis für HNO Heilkunde, Allergologie und plastische Chirurgie

Wiesbaden, , Germany

Site Status

Hals, Nasen- u. Ohrenheilkunde Willich

Willich, , Germany

Site Status

Gemeinschaftspraxis für Hals-Nasen-Ohrenheilkunde

Wuppertal, , Germany

Site Status

Meander Medisch Centrum, lokatie Baarn, Afdeling KNO

Amersfoort, , Netherlands

Site Status

Allergologen Maatschap Arnhem

Arnhem, , Netherlands

Site Status

Wilhelmina Ziekenhuis Assen, Afdeling KNO

Assen, , Netherlands

Site Status

Vlietland Ziekenhuis, lokatie Schiedam, KNO

Schiedam, , Netherlands

Site Status

Medical University of Bialystok, Department of Pediatrics and Allergology

Bialystok, , Poland

Site Status

Medical University of Gdansk, Department of Allergology

Gdansk, , Poland

Site Status

FARMA-MED. Sp. z o. o.

Inowrocław, , Poland

Site Status

Jagiellonian University Medical College, Department of Allergy and Immunology

Krakow, , Poland

Site Status

Jagiellonian University Medical College, Department of Allergology and Dermatology

Krakow, , Poland

Site Status

Klinika Pneumonologii i Alergologii Uniwersytet Medyczny w Lodzi

Lodz, , Poland

Site Status

NZOZ Centrum Alergologii

Lodz, , Poland

Site Status

Medical University of Lodz, Department of Allergology and Pulmonology

Lodz, , Poland

Site Status

Medical University of Lodz, Department of Clinical Immunology and Allergy

Lodz, , Poland

Site Status

Medical University of Lodz, Department of Pediatrics and Allergology

Lodz, , Poland

Site Status

Medical University of Lublin, Department of Allergology and Immunotherapy

Lublin, , Poland

Site Status

Klinika Pneumonologii Onkologii i Alergologii SPSK Nr 4

Lublin, , Poland

Site Status

Oddzial Dzieciecy SPZOZ

Pabianice, , Poland

Site Status

Institute of Allergy and Lung Disease Rabka, Department of Allergology and Pneumonology

Rabka-Zdrój, , Poland

Site Status

Specjalistyczny Zespól Diagnostyczno-Konsultacyjny Problemów Alergii Emil Florkiewicz

Sieradz, , Poland

Site Status

Gabinet Lekarski Bozena Kubicka-Kozik Poradnia Alergologiczna

Tomaszów Mazowiecki, , Poland

Site Status

Specjalistyczny Niepubliczny Zaklad Leczenia Alergii i Diagnostyki Alergologicznej IRMED 2

Warsaw, , Poland

Site Status

Military Institute of the Health Services, Department of Infection Disease and Allergology

Warsaw, , Poland

Site Status

Military Institute of the Health Services, Department of Internal Disease Pulmonology and Allergology

Warsaw, , Poland

Site Status

Medical University of Wroclaw, Department of Internal Disease and Allergology

Wroclaw, , Poland

Site Status

Medical University of Silesia, Department of Internal Disease, Allergology and Clinical Immunology

Zabrze, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Germany Netherlands Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EudraCTnr: 2005-005175-16

Identifier Type: -

Identifier Source: secondary_id

SG/0021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SUBLIVAC® Birch PROBE Study
NCT00932607 COMPLETED PHASE2